TY - JOUR
T1 - BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen
AU - Xia, Yu
AU - Sandor, Katalin
AU - Pai, Joy A.
AU - Daniel, Bence
AU - Raju, Saravanan
AU - Wu, Renee
AU - Hsiung, Sunnie
AU - Qi, Yanyan
AU - Yangdon, Tenzin
AU - Okamoto, Mariko
AU - Chou, Chun
AU - Hiam-Galvez, Kamir J.
AU - Schreiber, Robert D.
AU - Murphy, Kenneth M.
AU - Satpathy, Ansuman T.
AU - Egawa, Takeshi
N1 - Funding Information:
A.T.S. is a scientific co-founder of Immunai, founder of Cartography Biosciences, and receives research funding from Arsenal Biosciences, Merck Research Laboratories, and Allogene Therapeutics.
Funding Information:
We thank the NIH tetramer core at Emory for providing the I-A b -LCMV-gp66 tetramers. This study was supported by NIH grants R01AI130152 (to T.E.), R21AI161040 (to T.E.), F30CA247262 (to R.W.), T32AI007290 (to J.A.P.), K08CA230188 (to A.T.S.), U01CA260852 (to A.T.S.), UM1HG012076 (to A.T.S.), R01CA190700 (to R.D.S.), P30AR073752 (Rheumatic Diseases Research Resource-Based Center at Washington University), the Leukemia and Lymphoma Society Scholar Award (to T.E.), Stanford Propel Scholarship (to K.J.H.-G.), the Parker Institute for Cancer Immunotherapy (to A.T.S. and R.D.S.), the Burroughs Wellcome Fund Career Award for Medical Scientists (to A.T.S.), a Technology Impact Award from the Cancer Research Institute (to A.T.S.), a Pew-Stewart Scholars for Cancer Research Award (to A.T.S.), and a Baxter Foundation Scholar Award (to A.T.S.).
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/7/12
Y1 - 2022/7/12
N2 - Soon after activation, CD4+ T cells are segregated into BCL6+ follicular helper (Tfh) and BCL6– effector (Teff) T cells. Here, we explored how these subsets are maintained during chronic antigen stimulation using the mouse chronic LCMV infection model. Using single cell-transcriptomic and epigenomic analyses, we identified a population of PD-1+ TCF-1+ CD4+ T cells with memory-like features. TCR clonal tracing and adoptive transfer experiments demonstrated that these cells have self-renewal capacity and continue to give rise to both Teff and Tfh cells, thus functioning as progenitor cells. Conditional deletion experiments showed Bcl6-dependent development of these progenitors, which were essential for sustaining antigen-specific CD4+ T cell responses to chronic infection. An analogous CD4+ T cell population developed in draining lymph nodes in response to tumors. Our study reveals the heterogeneity and plasticity of CD4+ T cells during persistent antigen exposure and highlights their population dynamics through a stable, bipotent intermediate state.
AB - Soon after activation, CD4+ T cells are segregated into BCL6+ follicular helper (Tfh) and BCL6– effector (Teff) T cells. Here, we explored how these subsets are maintained during chronic antigen stimulation using the mouse chronic LCMV infection model. Using single cell-transcriptomic and epigenomic analyses, we identified a population of PD-1+ TCF-1+ CD4+ T cells with memory-like features. TCR clonal tracing and adoptive transfer experiments demonstrated that these cells have self-renewal capacity and continue to give rise to both Teff and Tfh cells, thus functioning as progenitor cells. Conditional deletion experiments showed Bcl6-dependent development of these progenitors, which were essential for sustaining antigen-specific CD4+ T cell responses to chronic infection. An analogous CD4+ T cell population developed in draining lymph nodes in response to tumors. Our study reveals the heterogeneity and plasticity of CD4+ T cells during persistent antigen exposure and highlights their population dynamics through a stable, bipotent intermediate state.
KW - anti-tumor immunity
KW - CD4 T cells
KW - chronic viral infection
KW - effector T cells
KW - follicular helper T cells
KW - progenitor cells
KW - single-cell genomics
UR - http://www.scopus.com/inward/record.url?scp=85134355165&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2022.05.003
DO - 10.1016/j.immuni.2022.05.003
M3 - Article
C2 - 35637103
AN - SCOPUS:85134355165
VL - 55
SP - 1200-1215.e6
JO - Immunity
JF - Immunity
SN - 1074-7613
IS - 7
ER -